1. Home
  2. RCUS vs QBTS Comparison

RCUS vs QBTS Comparison

Compare RCUS & QBTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • QBTS
  • Stock Information
  • Founded
  • RCUS 2015
  • QBTS 1999
  • Country
  • RCUS United States
  • QBTS Canada
  • Employees
  • RCUS N/A
  • QBTS N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • QBTS Retail: Computer Software & Peripheral Equipment
  • Sector
  • RCUS Health Care
  • QBTS Technology
  • Exchange
  • RCUS Nasdaq
  • QBTS Nasdaq
  • Market Cap
  • RCUS 1.4B
  • QBTS 1.4B
  • IPO Year
  • RCUS 2018
  • QBTS N/A
  • Fundamental
  • Price
  • RCUS $14.15
  • QBTS $6.29
  • Analyst Decision
  • RCUS Buy
  • QBTS Strong Buy
  • Analyst Count
  • RCUS 12
  • QBTS 6
  • Target Price
  • RCUS $34.50
  • QBTS $6.38
  • AVG Volume (30 Days)
  • RCUS 583.4K
  • QBTS 104.0M
  • Earning Date
  • RCUS 02-19-2025
  • QBTS 11-14-2024
  • Dividend Yield
  • RCUS N/A
  • QBTS N/A
  • EPS Growth
  • RCUS N/A
  • QBTS N/A
  • EPS
  • RCUS N/A
  • QBTS N/A
  • Revenue
  • RCUS $263,000,000.00
  • QBTS $9,424,000.00
  • Revenue This Year
  • RCUS $127.65
  • QBTS $4.94
  • Revenue Next Year
  • RCUS N/A
  • QBTS $63.93
  • P/E Ratio
  • RCUS N/A
  • QBTS N/A
  • Revenue Growth
  • RCUS 119.17
  • QBTS 14.27
  • 52 Week Low
  • RCUS $13.51
  • QBTS $0.71
  • 52 Week High
  • RCUS $20.31
  • QBTS $11.41
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 39.00
  • QBTS 49.97
  • Support Level
  • RCUS $13.81
  • QBTS $5.23
  • Resistance Level
  • RCUS $14.45
  • QBTS $6.44
  • Average True Range (ATR)
  • RCUS 0.57
  • QBTS 1.27
  • MACD
  • RCUS -0.06
  • QBTS -0.48
  • Stochastic Oscillator
  • RCUS 30.40
  • QBTS 37.28

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. The Company's mission is to unlock the power of quantum computing today to benefit business and society. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the Company's LeapTM cloud service.

Share on Social Networks: